CLINICALLY SPEAKING DermACELL : Human Acellular Dermal Matrix Allograft

Diabetes often causes ulcers on the feet of diabetic patients. A 56-year-old, insulindependent, diabetic woman presented to the wound care center with a Wagner grade 3 ulcer of the right heel. She reported a 3-week history of ulceration with moderate drainage and odor and had a history of ulceration and osteomyelitis in the contralateral limb. Rigorous wound care, including hospitalization; surgical incision and drainage; intravenous antibiotic drug therapy; vacuum-assisted therapy; and a new room temperature, sterile, human acellular dermal matrix graft were used to heal the wound, save her limb, and restore her activities of daily living. This case presentation involves alternative treatment of a diabetic foot ulcer with this new acellular dermal matrix, DermACELL. (J Am Podiatr Med Assoc 106(2): 133-137, 2016)